“…blocking of glutamatergic inhibitory regulation. Indeed, we have reported that cortical NPY neuronal system is controlled, at least partly, by glutamatergic inputs via NMDA receptor-mediated mechanisms (Fukui et al, 1995). It has been reported, however, the PCP treatment influences other neurotransmitters and their receptors such as serotonin (Nabeshima et al, 1981), GABA (Nabeshima et al, 1984) and o receptor (Junien and Leonard, 1989), further studies are necessary to confirm our findings due to the direct influence of PCP on glutamatergic or indirectly on other neurotransmitters, or both.…”